Logo image of NXU

NXU INC (NXU) Stock Fundamental Analysis

NASDAQ:NXU - Nasdaq - US62956D2045 - Common Stock - Currency: USD

2.45  -0.1 (-3.92%)

After market: 2.34 -0.11 (-4.49%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NXU. NXU was compared to 121 industry peers in the Specialty Retail industry. NXU has a bad profitability rating. Also its financial health evaluation is rather negative. NXU is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NXU had negative earnings in the past year.
NXU had a negative operating cash flow in the past year.
NXU had negative earnings in each of the past 5 years.
In the past 5 years NXU always reported negative operating cash flow.
NXU Yearly Net Income VS EBIT VS OCF VS FCFNXU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

NXU has a Return On Assets of -280.11%. This is amonst the worse of the industry: NXU underperforms 97.52% of its industry peers.
Looking at the Return On Equity, with a value of -393.70%, NXU is doing worse than 79.34% of the companies in the same industry.
Industry RankSector Rank
ROA -280.11%
ROE -393.7%
ROIC N/A
ROA(3y)-529.14%
ROA(5y)-1853.26%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NXU Yearly ROA, ROE, ROICNXU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NXU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXU Yearly Profit, Operating, Gross MarginsNXU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 -20K -40K -60K -80K -100K

More info and screens

3

2. Health

2.1 Basic Checks

NXU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NXU has more shares outstanding
Compared to 5 years ago, NXU has more shares outstanding
NXU has a better debt/assets ratio than last year.
NXU Yearly Shares OutstandingNXU Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
NXU Yearly Total Debt VS Total AssetsNXU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

NXU has an Altman-Z score of -53.86. This is a bad value and indicates that NXU is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -53.86, NXU is doing worse than 90.91% of the companies in the same industry.
NXU has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.00, NXU is doing good in the industry, outperforming 72.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -53.86
ROIC/WACCN/A
WACC9.07%
NXU Yearly LT Debt VS Equity VS FCFNXU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

2.3 Liquidity

A Current Ratio of 1.82 indicates that NXU should not have too much problems paying its short term obligations.
NXU's Current ratio of 1.82 is fine compared to the rest of the industry. NXU outperforms 79.34% of its industry peers.
NXU has a Quick Ratio of 1.82. This is a normal value and indicates that NXU is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NXU (1.82) is better than 88.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.82
NXU Yearly Current Assets VS Current LiabilitesNXU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 94.46% over the past year.
Looking at the last year, NXU shows a very negative growth in Revenue. The Revenue has decreased by -96.37% in the last year.
EPS 1Y (TTM)94.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.62%
Revenue 1Y (TTM)-96.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-99.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y97.42%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NXU Yearly Revenue VS EstimatesNXU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 100K 200K 300K 400K
NXU Yearly EPS VS EstimatesNXU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 -50 -100 -150 -200 -250

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NXU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXU Price Earnings VS Forward Price EarningsNXU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXU Per share dataNXU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NXU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NXU INC

NASDAQ:NXU (4/9/2025, 8:00:02 PM)

After market: 2.34 -0.11 (-4.49%)

2.45

-0.1 (-3.92%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-17 2025-03-17/bmo
Earnings (Next)N/A N/A
Inst Owners2.3%
Inst Owner Change-0.28%
Ins Owners16.28%
Ins Owner Change0.07%
Market Cap6.08M
Analysts45
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.34%
Min EPS beat(2)-44.06%
Max EPS beat(2)-38.61%
EPS beat(4)1
Avg EPS beat(4)-22.41%
Min EPS beat(4)-44.06%
Max EPS beat(4)4.15%
EPS beat(8)3
Avg EPS beat(8)-146.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-1900%
EPS NQ rev (3m)-1233.33%
EPS NY rev (1m)0%
EPS NY rev (3m)18.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 337.56
P/FCF N/A
P/OCF N/A
P/B 1.01
P/tB 1.01
EV/EBITDA N/A
EPS(TTM)-15.68
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-5.64
FCFYN/A
OCF(TTM)-4.87
OCFYN/A
SpS0.01
BVpS2.43
TBVpS2.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -280.11%
ROE -393.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-529.14%
ROA(5y)-1853.26%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 227.46%
Cap/Sales 10538.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.82
Altman-Z -53.86
F-Score4
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)354.83%
Cap/Depr(5y)582.89%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.62%
EPS Next Y97.42%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-96.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-99.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.52%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.85%
OCF growth 3YN/A
OCF growth 5YN/A